In brief, we found that both NGAL and KIM-1, but not TIMP-2×IGFBP-7, measured at the first or second cisplatin cycle (EV), especially at the 3–5-day postinfusion discharge sample, were higher in patients who later had signs of CKD. The gene discussed is LCN2; the disease is chronic kidney disease.